Global Oncology Awards Ceremony
Yvonne Awards 2024
Overview
Event Highlights
- The Yvonne Award celebrated excellence, resilience, leadership, and innovation across the global oncology community.
- More than 1,500 guests registered for the ceremony held during the 2024 ASCO Annual Meeting in Chicago.
- Individuals and organizations were recognized across eight categories, highlighting achievements beyond research alone—including mentorship, community oncology, advocacy, and humanitarian impact.
- The award brought together oncologists, researchers, leaders, and advocates from around the world to celebrate progress in cancer care.
- The international Nomination Committee helped ensure that the selection process reflected diverse expertise and perspectives from across oncology.
Venue
Revel Motors Row
2400 S. Michigan Ave, Chicago, IL 60616
Event Series
Date / Time
May 31, 2024 · 7:00 PM
The Yvonne Award by OncoDaily, inspired by the strength and longevity of the yew tree, honored exceptional achievements in oncology. Its distinctive Y-shaped sculpture represented resilience, perseverance, and the enduring commitment of those working to improve cancer care.
Created to recognize innovators and emerging leaders, the Yvonne Award celebrated individuals and organizations demonstrating excellence, leadership, and a commitment to advancing oncology worldwide.
The Yvonne Award Ceremony took place at Revel Motors Row on May 31, 2024, during the ASCO Annual Meeting.
Oncology professionals from around the world gathered to celebrate scientific progress, innovation, leadership, and service across the cancer care community.
More than 1,500 guests registered for the event, which opened with remarks from Gevorg Tamamyan, Editor-in-Chief and Co-Founder of OncoDaily.
OncoDaily extends its sincere gratitude to the guests, members of the Yvonne Award Nomination Committee, award presenters, nominees, and recipients who helped make the 2024 celebration a memorable occasion.
Yvonne Award 2024 Recipients
The 2024 Yvonne Award program recognized outstanding individuals and organizations across eight categories:
• Breakthrough Research: Vinod Balachandran
• Leadership: Asya Agulnik
• Global Oncology: Haimanot Kasahun Alemu
• Challenging the Status Quo: Pashtoon Kasi and Erica Tsang
• Voice of Oncology: Vivek Subbiah
• Community Oncology: Foluke Sarimiye and Abeid Athman Omar
• Mentorship: Anna Spreafico and Maria Babak
• Humanitarian Award: Aladina Foundation, presented in September 2024

Yvonne Award 2024 Recipients
The 2024 Yvonne Award program recognized outstanding individuals and organizations across eight categories:
• Breakthrough Research: Vinod Balachandran
• Leadership: Asya Agulnik
• Global Oncology: Haimanot Kasahun Alemu
• Challenging the Status Quo: Pashtoon Kasi and Erica Tsang
• Voice of Oncology: Vivek Subbiah
• Community Oncology: Foluke Sarimiye and Abeid Athman Omar
• Mentorship: Anna Spreafico and Maria Babak
• Humanitarian Award: Aladina Foundation, presented in September 2024

2024 Eligibility and Nomination Requirements
For the 2024 Yvonne Award, candidates were required to be within 10 years of receiving their terminal degree or initial faculty appointment. Both trainees and experienced professionals could be nominated, provided they met the applicable eligibility requirements.
Award recipients were required to attend the ASCO Annual Meeting and the Yvonne Award Ceremony in person on May 31, 2024.
Each nomination included:
• The name and email address of the nominee
• The name and email address of the nominator
• A description of why the nominee should receive the Yvonne Award, limited to 100 words
• One selected nomination category
• The nominee’s most recent curriculum vitae, limited to two pages
Nominations were accepted through the official nomination form or by email at info@oncodaily.com.
The nomination deadline was May 10, 2024.
2024 Nomination Categories
Candidates could be nominated in one of the following categories:
• Breakthrough Research
• Global Oncology
• Community Oncology
• Leadership
• Mentorship
• Challenging the Status Quo
Yvonne Award Nomination Committee - Co-Chairs
Lillian Siu – Director of the Phase I Clinical Trials Program and Co-Director of the Bras and Family Drug Development Program; Clinical Lead for the Tumor Immunotherapy Program; BMO Chair in Precision Genomics at Princess Margaret Cancer Centre; Professor of Medicine at the University of Toronto; 2024–2025 President-Elect of the American Association for Cancer Research; recipient of the 2024 ASCO David Karnofsky Memorial Award.
Giuseppe Curigliano – Professor of Medical Oncology at the University of Milan; Chief of the Clinical Division of Early Drug Development at the European Institute of Oncology; Chair of the ESMO Clinical Practice Guidelines Committee; Member of the Italian Higher Health Council.
Yvonne Award Nomination Committee - Members
Larry Norton – Senior Vice President of Memorial Sloan Kettering Cancer Center; Medical Director of the Evelyn H. Lauder Breast Center; Norna S. Sarofim Chair in Clinical Oncology; Professor of Medicine at Weill Cornell Medical College; Founder and Scientific Director of the Breast Cancer Research Foundation; Past President of ASCO; Past Chair of the ASCO Conquer Cancer Foundation; recipient of the 2004 ASCO David Karnofsky Memorial Award.
Lidia Schapira – Professor of Medicine at Stanford University School of Medicine; Director of the Cancer Survivorship Program; Faculty Co-Director for Clinical Research and Clinical Trials in the Office of Cancer Health Equity at Stanford Cancer Institute; Associate Editor of the Journal of Clinical Oncology.
Greg Kalemkerian – Professor of Internal Medicine at the University of Michigan; Associate Division Chief for Faculty Development and Education; Associate Director of the Hematology/Oncology Fellowship Program; Chair of the NCCN Small Cell Lung Cancer Guideline Panel.
Leo Mascarenhas – Division Chief and Director of Pediatric Hematology/Oncology at Cedars-Sinai Guerin Children’s; Director of the Sarcoma Program at Cedars-Sinai Cancer; Professor of Pediatrics at Cedars-Sinai Medical Center.
Justin Stebbing – Editor-in-Chief of Oncogene; Visiting Professor of Cancer Medicine and Oncology at Imperial College London; Professor of Biomedical Sciences at Anglia Ruskin University, Cambridge.
Piotr Wysocki – Professor and Head of the Clinical Oncology Department at Jagiellonian University Medical College; Past President of the Polish Society of Clinical Oncology; Chair of the ASCO European Regional Council.
Liana Safaryan – Chief of the Department of Oncology at the Yeolyan Hematology and Oncology Center.
Marina Konopleva – Professor of Oncology and Molecular Pharmacology; Director of the Leukemia Program; Co-Director of the Blood Cancer Institute at Montefiore Einstein; Professor in the Department of Leukemia at MD Anderson Cancer Center.
Dinesh Pendharkar – Director of Oncology at Sarvodaya Hospital Faridabad; Chairman of the National Cancer Society; Past President of the Indian Society of Oncology; Past President of the Indian Society of Medical and Paediatric Oncology.
Maite Bourlon – Associate Professor and Head of the Urologic Oncology Clinic at Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán; Director of the Genitourinary Cancers Program at Universidad Nacional Autónoma de México; Chair-Elect of the ASCO IDEA Steering Group.
Nazik Hammad – Professor in the Division of Hematology-Oncology at St. Michael’s Hospital, University of Toronto; Chair of the Education and Training Committee of the African Organisation for Research and Training in Cancer; Executive Member of the Global Oncology Program at Queen’s University.
Aparna Parikh – Assistant Professor of Medicine at Harvard Medical School; Director of the Global Cancer Care Program at Massachusetts General Hospital.
Ghassan Abou-Alfa – Professor of Medicine at Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; Immediate Past Chair of the National Cancer Institute Hepatobiliary Task Force.
Douglas Flora – Editor-in-Chief of AI in Precision Oncology; Executive Medical Director of Oncology Services at St. Elizabeth Healthcare; Vice Chair of the American Cancer Society Board; Treasurer of the Association of Cancer Care Centers Executive Committee.
Onyinye Balogun – Assistant Professor of Radiation Oncology at Weill Cornell Medicine; Co-Founder and Chief Medical Officer of Mission-Driven Tech.
Herbert Loong – Clinical Associate Professor in the Department of Clinical Oncology and Deputy Medical Director of the Phase 1 Clinical Trial Centre at the Chinese University of Hong Kong; Honorary Consultant in the Department of Clinical Oncology at Prince of Wales Hospital; Chair-Elect of the ASCO International Committee.
Miriam Mutebi – President of the African Organisation for Research and Training in Cancer; Immediate Past President of the Kenya Society of Hematology and Oncology; Member of the Board of Directors of the Union for International Cancer Control; Assistant Professor in the Department of Surgery at Aga Khan University Hospital in Nairobi, Kenya; Co-Founder of the Pan African Women’s Association of Surgeons; recipient of the 2024 ASCO Humanitarian Award.
About OncoDaily
Founded in 2023, OncoDaily is a US-based oncology media platform featuring the latest news, expert insights, research developments, professional opportunities, and patient stories from across the world of oncology. Within a short period, it became one of the leading global oncology media platforms.
OncoDaily brings together content from numerous sources, including leading oncology professionals, medical societies, cancer centers, patients, survivors, and advocacy organizations.
Its mission is to empower patients, survivors, and professionals with the knowledge and inspiration they need in the fight against cancer.
“Cancer doesn’t take a day off—neither do we.”